コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ure and fatal metabolic liver disease due to fumarylacetoacetate dehydrolase (Fah) deficiency, hiHeps
3 tary tyrosinemia type 1 have a deficiency of fumarylacetoacetate hydrolase (FAH) and develop progress
4 tyrosine catabolism caused by deficiency of fumarylacetoacetate hydrolase (FAH) and homogentisic aci
6 ss of the remaining Hgd allele protects from fumarylacetoacetate hydrolase (Fah) deficiency, a geneti
11 tic genotoxicity in vivo, we transferred the fumarylacetoacetate hydrolase (FAH) gene by LV vectors i
12 associated with point mutations in the human fumarylacetoacetate hydrolase (FAH) gene that disrupt ty
13 tis B virus X (HBx) gene, into the livers of fumarylacetoacetate hydrolase (Fah) mutant mice via hydr
14 analysis identified 4-OD as a member of the fumarylacetoacetate hydrolase (FAH) superfamily and impl
15 essive liver disease caused by deficiency of fumarylacetoacetate hydrolase (FAH), to determine whethe
17 inemia and show that the treatment generated fumarylacetoacetate hydrolase (Fah)-positive hepatocytes
20 cells into syngeneic recipients deficient in fumarylacetoacetate hydrolase and manifesting tyrosinemi
22 ocytes can repopulate the liver of mice with fumarylacetoacetate hydrolase deficiency and correct the
23 serial transplantation of hepatocytes in the fumarylacetoacetate hydrolase deficiency murine model of
28 osinaemia type I, mice with mutations in the fumarylacetoacetate hydrolase gene (Fah-/-) regain norma
30 aperitoneal injection into 8- to 12-week-old fumarylacetoacetate hydrolase mice (Fah(-/-)), a model o
32 al recessive disease caused by deficiency in fumarylacetoacetate hydrolase, the last enzyme in the ty
33 ion of human hepatocytes in immunodeficient, fumarylacetoacetate hydrolase-deficient (fah(-/-)) mice.
35 mice long after death and transplanted into fumarylacetoacetate hydrolase-deficient mice, a model fo
36 iparum LS in vivo: the immunocompromised and fumarylacetoacetate hydrolase-deficient mouse (Fah-/-, R
39 trans isomerisation of maleylacetoacetate to fumarylacetoacetate is the penultimate step in the tyros
40 e enzymatic defect impairs the conversion of fumarylacetoacetate to fumarate, causing accumulation of
41 drolytic cleavage of a carbon-carbon bond in fumarylacetoacetate to yield fumarate and acetoacetate a
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。